Drag a card by its title · ⚙ to size, swap or remove

The company

GRAIL, Inc.

GRAL · Nasdaq

Health CareDiagnostics & LabsJust started moving

GRAL stood above a rising 150-day average in 20 of the last 52 weekly readings, including each of the last 3 weeks. It is 60.9% above that average now. Diagnostics & Labs: 48% of its 44 stocks in an uptrend (−2 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: Just started moving
Weeks in an uptrend: 3 in a row
Industry in uptrend: 48% -2 in 4 wk
Insider buys, 12 months: $0
Insider sales, 12 months: $141.0M
Officials’ trades on record: 0
Institutions holding: 353 (+5)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 20 of 52 weeks.

17 Apr – 16 Oct

Diagnostics & Labs: About half its stocks are in an uptrend and the share has held steady. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0

Sale orders, 12 months25

Buyers · sellers0 · 5

Who	Did	Shares	Traded
Joshua J. OfmanChief Executive Officer	sold	400at $133.12	15 Oct 2026filed 16 Oct 2026
Joshua J. OfmanChief Executive Officer	sold	1,000at $134.38	15 Oct 2026filed 16 Oct 2026
Joshua J. OfmanChief Executive Officer	sold	3,400at $135.44	15 Oct 2026filed 16 Oct 2026
Joshua J. OfmanChief Executive Officer	sold	7,052at $136.83	15 Oct 2026filed 16 Oct 2026
Joshua J. OfmanChief Executive Officer	sold	6,034at $137.63	15 Oct 2026filed 16 Oct 2026
Joshua J. OfmanChief Executive Officer	sold	2,114at $138.79	15 Oct 2026filed 16 Oct 2026
Aaron FreidinChief Financial Officer	sold	23,619at $146.39	5 Oct 2026filed 7 Oct 2026
Andrew John PartridgeChief Growth Officer	sold	7,873at $146.39	5 Oct 2026filed 7 Oct 2026
Joshua J. OfmanChief Executive Officer	sold	2,125at $92.32	21 Sep 2026filed 23 Sep 2026
Joshua J. OfmanChief Executive Officer	sold	1,454at $93.61	21 Sep 2026filed 23 Sep 2026
Joshua J. OfmanChief Executive Officer	sold	37,752at $94.98	21 Sep 2026filed 23 Sep 2026
Joshua J. OfmanChief Executive Officer	sold	6,200at $96.43	21 Sep 2026filed 23 Sep 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders353+5 on the quarter

New · exited61 · 54

Reported value$2.6B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
FARALLON CAPITAL MANAGEMENT, L.L.C.added · filed 14 Aug 2026	4,161,584$284.1M	+907,900+27.9%
BAKER BROS. ADVISORS LPunchanged · filed 14 Aug 2026	4,028,614$275.0M	00.0%
BlackRock, Inc.added · filed 7 Aug 2026	3,577,075$244.2M	+608,539+20.5%
STATE STREET CORPadded · filed 7 Aug 2026	2,385,514$162.9M	+493,621+26.1%
PRIMECAP MANAGEMENT COadded · filed 14 Aug 2026	2,180,106$148.8M	+336,334+18.2%
Sessa Capital IM, L.P.added · filed 14 Aug 2026	2,037,518$139.1M	+318,204+18.5%
Deep Track Capital, LPadded · filed 14 Aug 2026	1,834,944$125.3M	+112,147+6.5%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	1,641,117$112.0M	+114,012+7.5%
MORGAN STANLEYreduced · filed 13 Aug 2026	1,462,163$99.8M	-170,032−10.4%
Arbiter Partners Capital Management LLCreduced · filed 10 Aug 2026	1,034,297$70.6M	-3000.0%